The Gut Microbiome: A Therapeutically Targetable Site of Peripheral Levodopa Metabolism
Mov Disord Clin Pract
.
2019 Aug 26;6(7):547-548.
doi: 10.1002/mdc3.12828.
eCollection 2019 Sep.
Authors
Eoin Mulroy
1
,
Kailash P Bhatia
1
Affiliation
1
Department of Clinical and Movement Neurosciences University College London Queen Square Institute of Neurology London United Kingdom.
PMID:
31538088
PMCID:
PMC6749799
DOI:
10.1002/mdc3.12828
No abstract available
Keywords:
Parkinson's disease; gastrointestinal microbiome; levodopa.